Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:ROKA

(ROKA) (ROKA) Stock Price, News & Analysis

(ROKA) logo

About (ROKA) Stock (NASDAQ:ROKA)

Advanced Chart

Key Stats

Today's Range
$0.65
$0.69
50-Day Range
N/A
52-Week Range
$0.60
$6.20
Volume
242,292 shs
Average Volume
371,374 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Sorrento Tech, Inc., formerly Roka Bioscience, Inc., is a molecular diagnostics company. The Company is focused on the development and commercialization of molecular assay technologies for the detection of foodborne pathogens under the Atlas brand name. The Company offers Atlas Detection Assays and Atlas instrument in the North American food safety testing market and has rights to develop and commercialize its molecular testing solutions for a range of other industrial applications. The detection of foodborne pathogens is accomplished using culture-based assays, immunochemical-based assays and molecular-based assays. The Company sells its Atlas Detection Assays and related consumable supplies for use with its Atlas instruments. The Company's Atlas instrument is an automated molecular diagnostic testing and a sample-in-result-out instrument that eliminates the need for batch processing and automates all aspects of molecular diagnostic testing on a single, integrated platform.

Receive ROKA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for (ROKA) and its competitors with MarketBeat's FREE daily newsletter.

ROKA Stock News Headlines

What a “Mar-a-Lago Accord” could mean for the US dollar.
25-Year Market Vet Issues Urgent Dollar Warning He's spent 25 years tracking the flow of global money - now he's coming forward with an urgent warning about a D.C. plan to deliberately crash the dollar. If it succeeds, you could see 40% of your savings vanish overnight. This free video explains why and gives you four important steps to take immediately.
See More Headlines

ROKA Stock Analysis - Frequently Asked Questions

(ROKA) (NASDAQ:ROKA) announced its quarterly earnings data on Thursday, May, 11th. The medical research company reported ($1.53) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($1.19) by $0.34. The medical research company had revenue of $2.04 million for the quarter.

Based on aggregate information from My MarketBeat watchlists, some other companies that (ROKA) investors own include Credit Suisse High Yield Bond Fund (DHY), Western Asset High Income Fund II (HIX), Pimco Corporate & Income Opportunity Fund (PTY), ASML (ASML), Corbus Pharmaceuticals (CRBP), Stag Industrial (STAG) and Twitter (TWTR).

Company Calendar

Last Earnings
5/11/2017
Today
6/20/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
N/A
Industry
N/A
Sub-Industry
N/A
Current Symbol
NASDAQ:ROKA
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for June 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

This page (NASDAQ:ROKA) was last updated on 6/20/2025 by MarketBeat.com Staff
From Our Partners